Vaccines 2.0 - developing the next generation of vaccines

This section details the entities eligible for funding under the 'Vaccines 2.0' program, focusing on their types, geographical reach, and the overarching objectives of the initiative. The program aims to support a diverse range of organizations globally to combat infectious diseases and reduce their burden.

This section outlines the specific types of projects, thematic areas, and activities supported by the 'Vaccines 2.0' program. It details the focus on research and innovation actions aimed at developing advanced vaccine solutions, from fundamental discovery to clinical validation.

This section describes the financial nature of the 'Vaccines 2.0' program, including the type of funding instrument and the financial scale of individual projects.

This section outlines the general and specific conditions governing applications and project implementation under the 'Vaccines 2.0' program. Adherence to these conditions, detailed in various annexes of the Horizon Europe Work Programme General Annexes, is crucial for eligibility and successful project execution.

This section outlines the multi-stage application and evaluation process for the 'Vaccines 2.0' program, detailing submission requirements, evaluation criteria, and communication of results.

This section identifies the foundational legal and policy documents that authorize and govern the 'Vaccines 2.0' funding program, rooted in the broader framework of Horizon Europe.